ClinConnect ClinConnect Logo
Search / Trial NCT06890208

Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures, Third Wave

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Mar 16, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

The CLIMATE-III Observational Study is looking into how heat affects people with chronic illnesses, like heart disease, diabetes, and lung problems. Researchers want to understand if different factors, like how well patients manage their health and where they live, impact their experience with heat-related health issues. The study will involve participants from Germany and Italy, and it aims to gather important information to help improve care for these patients during hot weather.

To be eligible for this study, participants must be 18 years or older and have at least one of the specified health conditions, such as heart disease or diabetes. Unfortunately, people who cannot give consent, have severe vision problems, or struggle with the German language will not be able to join. If you participate, you can expect to share your experiences and thoughts about how heat affects your health, which could help shape future support for patients like you. This study is not yet recruiting, but it is an important step toward understanding the challenges faced by those with chronic illnesses in hot weather.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • being 18 years or older
  • at least one of the following conditions: Coronary Heart Disease; Myocardial Infarction; Heart Failure; Cardiac Arrhythmias; Peripheral Artery Disease; Stroke; Transient Ischemic Attack; Diabetes Mellitus (Type 1 or 2); Chronic Obstructive Pulmonary Disease; Asthma; Renal Insufficiency; Depressive Disorder; Anxiety Disorders; Schizophrenia; Peripheral Nervous System Diseases.
  • Exclusion Criteria:
  • no capacity to consent
  • severe visual impairment
  • insufficient German language skills
  • not able to use internet browser (eg, lack of hardware)

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Patients applied

0 patients applied

Trial Officials

Ingmar Schäfer, PD Dr.

Principal Investigator

Universitätsklinikum Hamburg-Eppendorf

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported